At OCTSC, an expert delved into how to optimise patient enrollment to achieve retention and clinical trial success.

Applied Clinical Trials recently conducted its State of the Industry survey, capturing perspectives on the current clinical ...

While clinical trials help to advance the treatment landscape in breast cancer care, many myths remain; however, Dr. Reshma Mahtani aims to demystify these moving forward. At the CURE® Educated ...

Trial is evaluating ciforadenant as a potential first line therapy for metastatic renal cell cancer (RCC) in combination with ipilimumab ...

MN-166 (ibudilast) is a small molecule compound that inhibits phosphodiesterase type-4 (PDE4) and inflammatory cytokines, including macrophage migration inhibitory factor (MIF). It is in late-stage ...

SAN DIEGO--(BUSINESS WIRE)--Calidi Biotherapeutics, Inc. (NYSE American: CLDI or “Calidi”), a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today ...

Title: A phase 1 trial evaluating the safety, tolerability, PK, and preliminary efficacy of QTX3034, an oral G12D-preferring allosteric KRAS inhibitor, in patients with solid tumors with KRASG12D ...

ALX Oncology Holdings Inc. announced that the updated results from its Phase 2 ASPEN-06 clinical trial have been accepted for oral presentation at the 2025 American Society of Clinical Oncology ...

Additional analyses of clinical and microbiological data from the Phase 2b segment show favorable gut microbiome changes including increased relative proportion of Actinobacteria in ...

While oncologists are helpful in helping patients to find clinical trials that are a right fit for them, nurses are equally essential in helping to enroll patients in these trials. At the at CURE® ...